Practical tips and tricks: Peer advice for identifying the glaucoma suspect and first line approaches
Mitch Ibach, OD, FAAO; Nate Lighthizer, OD, FAAO; and Austin Lifferth, OD, FAAO, discuss how they evaluate patients with borderline findings but significant risk factors
Determining when to treat a glaucoma suspect—and when to continue monitoring—remains one of the more nuanced challenges in clinical practice. In this Q&A, Mitch Ibach, OD, FAAO; Nate Lighthizer, OD, FAAO; and Austin Lifferth, OD, FAAO, discuss how they evaluate patients with borderline findings but significant risk factors, including the role of optical coherence tomography (OCT) imaging, visual field testing, pachymetry, and longitudinal follow-up in guiding management decisions. The conversation also explores how clinicians incorporate progression analysis software and risk assessment strategies into everyday glaucoma care.